Accessibility Menu
Cardio Diagnostics logo

Cardio Diagnostics(NASDAQ) CDIOW

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2022)-95%
5 YearN/A
1 Year-10%
1 Month+3%
$0.02
+26.81%
+0.00Today
Cardio Diagnostics last closing stock price
MetricPriceDate
Last closeUSD 0.022026-08-26
Cardio Diagnostics stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+19.86%USD 0.012026-08-18
1 month+3%USD 0.022026-07-27
3 month+33.58%USD 0.012026-05-28
Year to date-32.44%USD 0.032025-12-31
1 year-10.26%USD 0.022025-08-26
3 year-80.58%USD 0.092023-08-23
Since inception-94.7%USD 0.332022-01-14

Cardio Diagnostics Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$14.45K

Net Income (TTM)

-$6.47M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.58 (Low)

Price

$0.02

Volume

7,700

Open

$0.01

Previous Close

$0.02

Daily Range

$0.01 - $0.02

52-Week Range

$0.01 - $0.07

Estimated Earnings Date

Dec 2, 2026

CDIOW News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cardio Diagnostics

Cardio Diagnostics Holdings, Inc. is a biotechnology company founded in 2017, based in Chicago, Illinois. The company specializes in developing clinical tests that utilize epigenetics to evaluate cardiovascular disease risk, with a notable product being the Epi+Gen CHD test.

Products and Services
  • Epi+Gen CHD test for predicting coronary heart disease risk
  • Clinical tests leveraging epigenetic technology
  • Innovative diagnostic tools for cardiovascular health assessment
Growth Outlook
  • Market demand for cardiovascular diagnostics is increasing
  • Expansion of product offerings anticipated in the coming years
  • Potential partnerships with healthcare providers to enhance reach
Financial Highlights
  • Q2 2026 revenue of $5,360, showing growth from previous quarters
  • Cash and cash equivalents of $5.59 million as of June 30, 2026
  • Current ratio of 17.15 indicates strong liquidity position
Cardio Diagnostics Holdings, Inc. is positioned in a growing market focused on cardiovascular health, with innovative products that leverage cutting-edge technology. The company has shown a positive trend in revenue, indicating potential for future growth. With a strong liquidity position, the company is well-equipped to navigate the challenges of the biotechnology sector. The focus on expanding product offerings and potential partnerships may further enhance its market presence, making it an intriguing option for investors interested in the healthcare and biotechnology industries.
AI Generated • Aug 18, 2026

Industry

Biotechnology

Sector

Health Care

Headquarters

Chicago, IL 60654, US

CDIOW Financials

Key Financial Metrics (TTM)

Gross Margin

-555.03%

Operating Margin

-44690.68%

Net Income Margin

-44771.83%

Return on Equity

-82.27%

Return on Capital

-84.55%

Return on Assets

-81.62%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

0

Volume

7.70K

Avg. Volume

20.38K

Financials (TTM)

Gross Profit

-$80.20K

Operating Income

-$6.46M

EBITDA

-$6.17M

Operating Cash Flow

-$5.66M

Capital Expenditure

-$181.61K

Free Cash Flow

-$5.84M

Cash & ST Invst.

$5.59M

Total Debt

$369.70K

Cardio Diagnostics Performance Analysis

Cardio Diagnostics sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-61.8%
Q42025-12-3124.5%
Q12026-03-31-24.6%
Q22026-06-30100.0%
Cardio Diagnostics sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-1.0%
Q42025-12-3118.4%
Q12026-03-3121.3%
Q22026-06-3019.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$5.36K

-28.3%

Gross Profit

$5.36K

-28.3%

Gross Margin

100.00%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

15

N/A

Net Income

-$1.50M

+10.8%

EBITDA

-$1.49M

+6.1%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$5.59M

-29.9%

Total Debt

$369.70K

-32.3%

Accounts Receivable

$3.91K

-69.8%

Inventory

$0.00

N/A

Long Term Debt

$140.58K

-53.5%

Short Term Debt

$229.12K

-6.2%

Return on Assets

-81.62%

N/A

Return on Invested Capital

-85.34%

N/A

Free Cash Flow

-$1.34M

+15.6%

Operating Cash Flow

-$1.34M

+14.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CDIOCardio Diagnostics Holdings, Inc.
$1.93+1.05%
DRMAWDermata Therapeutics, Inc.
$0.00-50.00%
ICUCWSeaStar Medical Holding Corporation
$0.02-15.23%
OABIWOmniAb, Inc.
$0.30+30.43%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$209.66-0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.87-0.02%
BITOProShares Trust - ProShares Bitcoin ETF
$10.58-0.01%
INTCIntel
$88.24+0.01%

Questions About CDIOW

What is the current price of Cardio Diagnostics?

Cardio Diagnostics is trading at $0.02 per share.

What is the 52-week range for Cardio Diagnostics?

Over the past 52 weeks, Cardio Diagnostics has traded between $0.01 and $0.07.

How much debt does Cardio Diagnostics have?

Cardio Diagnostics total debt is unavailable.

How much cash does Cardio Diagnostics have on hand?

Cardio Diagnostics does not have cash on hand data available.

What is Cardio Diagnostics’s dividend yield?

Cardio Diagnostics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services